Proxy Votes Now

Home › Upcoming votes › MANGOCEUTICALS, INC.

MANGOCEUTICALS, INC. Annual Meeting December 30, 2026: What's on the Ballot

No fund votes on record from prior seasons.

Read the proxy statement on EDGAR

Proxy summary

Summary, checked against the proxy statement. Each point is backed by a passage of the filing, shown under the point; figures under “Last year’s votes” come from the company’s Form 8-K. Read the proxy statement before relying on it.

Combined 2025 and 2026 annual meeting: four directors, a reverse stock split, an equity plan amendment, auditor ratification and an adjournment proposal.

Key points

What changed from last year

What’s on the ballot

Ballot read from the proxy statement and checked. As listed in MANGOCEUTICALS, INC.’s proxy statement, with the board’s recommendation on each item.

#ItemProposed byBoard recommends
1 Election of four directors
Director election
Board For
2 Amendment to Certificate of Formation to effect a reverse stock split (1-for-2 to 1-for-25) Board For
3 Adoption of the Third Amendment to the 2022 Equity Incentive Plan Board For
4 Ratification of Turner, Stone & Company, L.L.P. as independent auditors for fiscal 2025 and 2026
Auditor
Board For
5 Adjournment of the Annual Meeting, if necessary
Adjournment
Board For

Filings for this meeting

About this page

The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.